Fresh2 Group Stock (NASDAQ: FRES) stock price, news, charts, stock research, profile.
Open | $1.43 |
Close | $1.38 |
Volume / Avg. | 15.42K / 7.60K |
Day Range | $1.37 - $1.66 |
52 Wk Range | 1.41 - 23.95 |
Market Cap | $35.57M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 0.02% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fresh2 Group (NASDAQ:FRES) through any online brokerage.
Other companies in Fresh2 Group’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
There is no analysis for Fresh2 Group to provide a consensus price target.
The stock price for Fresh2 Group (NASDAQ: FRES) is $1.45 last updated September 16, 2024 at 5:22 PM EDT.
There are no upcoming dividends for Fresh2 Group.
Fresh2 Group’s Q1 earnings are confirmed for Friday, September 27, 2024.
There is no upcoming split for Fresh2 Group.
Fresh2 Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.